Results 271 to 280 of about 7,285,650 (306)
Some of the next articles are maybe not open access.
Nature Reviews Immunology, 2007
Allogeneic haematopoietic stem-cell transplantation (SCT) is a curative therapy for haematological malignancies and inherited disorders of blood cells, such as sickle-cell anaemia. Mature alphabeta T cells that are contained in the allografts reconstitute T-cell immunity and can eradicate malignant cells in the recipient.
openaire +2 more sources
Allogeneic haematopoietic stem-cell transplantation (SCT) is a curative therapy for haematological malignancies and inherited disorders of blood cells, such as sickle-cell anaemia. Mature alphabeta T cells that are contained in the allografts reconstitute T-cell immunity and can eradicate malignant cells in the recipient.
openaire +2 more sources
Graft-versus-host disease and phimosis
Journal of Pediatric Urology, 2008Graft-versus-host disease rarely causes genitourinary problems. We report a case of pathological phimosis in a child secondary to chronic graft-versus-host disease.
S T, Patel +5 more
openaire +2 more sources
Chronic graft-versus-host disease
Current Opinion in Oncology, 2006Chronic graft-versus-host disease is an important cause of late morbidity and mortality after allogeneic stem cell transplantation. With the renewed interest in its pathophysiology and treatment, this review discusses recent clinical and laboratory advances in this disease. Advances in pathophysiology, the relationship between chronic graft-versus-host
Corey, Cutler, Joseph H, Antin
openaire +2 more sources
Enterococcus in Graft-versus-Host Disease
New England Journal of Medicine, 2020Susceptibility to Graft-versus-Host-Disease A major cause of poor outcome after allogeneic hematopoietic-cell transplantation is graft-versus-host disease.
openaire +2 more sources
Management of graft-versus-host disease
Transfusion Science, 1994Allogeneic bone marrow transplantation (BMT) involves transfer of primitive multipotential lymphohematopoietic stem cells from donor to recipient. In clinical transplantation, however, the aspirated marrow also contains substantial numbers of viable lymphoid cells, some originating from the marrow and some inadvertently collected by contamination of ...
openaire +2 more sources
Cutaneous Graft-versus-Host Disease
Archives of Dermatology, 1998Graft-versus-host disease (GvHD) includes inflammatory and/or fibrosing manifestations that may arise at various times after transplantation of any organ containing lymphoid cells. For the dermatologist, the importance of GvHD is real and current. Indeed, because it has become easier to perform bone marrow transplantation (EMT), the indications of BMT ...
S, Aractingi, O, Chosidow
openaire +2 more sources
Ocular graft-versus-host disease
Current Opinion in Allergy & Clinical Immunology, 2012This review was carried out to study the frequency, and severity of ocular surface involvement at the setting of allogeneic hematopoietic stem cell transplantation and subsequent graft-versus-host disease (GVHD) and evaluate the clinical outcomes of newer treatments.Ocular involvement has been reported in 60-90% of patients with chronic GVHD.
Michelle, Hessen, Esen K, Akpek
openaire +2 more sources
Oral Graft-Versus-Host Disease
Dental Clinics of North America, 2008Hematopoietic cell transplantation is used to treat malignancies, hematologic and immune deficiency states, marrow failure syndromes, and autoimmune diseases. Graft-versus-host disease (GVHD) is a clinical syndrome seen following allogeneic transplantation where donorderived immunocompetent T cells and inflammatory responses attack host tissues.
Mark M, Schubert +1 more
openaire +2 more sources
Vulvovaginal Graft-Versus-Host Disease
Obstetrics and Gynecology Clinics of North America, 2017Vulvovaginal chronic graft-versus-host disease (cGVHD) is an underrecognized complication of stem cell transplantation. Early recognition may prevent severe sequelae. Genital involvement is associated with oral, ocular, and skin manifestations. Treatment includes topical immunosuppression, dilator use, and adjuvant topical estrogen.
Rachel I, Kornik, Alison S, Rustagi
openaire +2 more sources
Infliximab in graft-versus-host disease
American Journal of Health-System Pharmacy, 2002Straightforward reports of unusual drug experiences are included in this section. While selected references may be cited, the purpose of a Drug Experience report is not to present an extensive review of the literature. A related section, Grand Rounds, includes papers that are well-documented patient case reports with a thorough review of the important ...
Anastasia M, Rivkina, Lisa S, Stump
openaire +2 more sources